Novaferon inhalation (recombinant anti-tumor and anti-virus protein inhalation) / Genova  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Novaferon inhalation (recombinant anti-tumor and anti-virus protein inhalation) / Genova
NCT05017714: A Trial of Novaferon in Asymptomatic or Mild COVID-19 Patients

Not yet recruiting
3
300
NA
Recombinant cytokine gene derived protein injection, Saline
Beijing 302 Hospital
SARS-CoV2 Infection
04/22
08/22
NOVATION-1, NCT04669015: Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

Recruiting
3
914
Canada, RoW
Novaferon, Standard of Care, Placebo
Genova Inc.
Covid19
08/22
08/22
NCT04708158: Novaferon for COVID-19 Treatment Trial (NCTT-005)

Recruiting
3
385
Japan
Novaferon, Placebo
Genova Inc.
Covid19
04/23
04/23

Download Options